Wilkins, John T.

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 12,591

Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 9,036

Heart disease and stroke statistics-2018 update: a report from the american heart association

Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 7,146

Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity.

Khan, S. S., Ning, H., Wilkins, J. T., Allen, N., Carnethon, M., Berry, J. D., Sweis, R. N., & Lloyd-Jones, D. M. (2018) · JAMA Cardiology

Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,072

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Lloyd-Jones, D. M., Morris, P. B., Ballantyne, C. M., Birtcher, K. K., Covington, A. M., DePalma, S. M., Minissian, M. B., Orringer, C. E., Smith, S. C., Waring, A. A., et al. (2022) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 569

Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: A primary prevention study

Quispe, R., Martin, S. S., Michos, E. D., Lamba, I., Blumenthal, R. S., Saeed, A., Lima, J., Puri, R., Nomura, S., Tsai, M., et al. (2021) · European Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 441

Associations of dietary cholesterol or egg consumption with incident cardiovascular disease and mortality.

Zhong, V. W., Van Horn, L., Cornelis, M. C., Wilkins, J. T., Ning, H., Carnethon, M. R., Greenland, P., Mentz, R. J., Tucker, K. L., Zhao, L., et al. (2019) · JAMA

Nutritional Studies and DietLipoproteins and Cardiovascular Health

Cited by 327

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia

Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · JACC

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 304

Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification

Wilkins, J. T., Li, R. C., Sniderman, A., Chan, C., & Lloyd-Jones, D. M. (2016) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthCardiac Imaging and Diagnostics

Cited by 181

PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Schmidt, A. F., Carter, J.-P. L., Pearce, L. S., Wilkins, J. T., Overington, J. P., Hingorani, A. D., & Casas, J. (2020) · Cochrane Database of Systematic Reviews

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 123

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., et al. (2026) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 122

Plaque composition in the proximal superficial femoral artery and peripheral artery disease events

McDermott, M. M., Kramer, C. M., Tian, L., Carr, J., Guralnik, J. M., Polonsky, T., Carroll, T., Kibbe, M., Criqui, M. H., Ferrucci, L., et al. (2017) · JACC: Cardiovascular Imaging

Peripheral Artery Disease ManagementAtherosclerosis and Cardiovascular Diseases

Cited by 55

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · Circulation

Lipoproteins and Cardiovascular HealthClinical practice guidelines implementation

Cited by 48

ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk

Sehayek, D., Cole, J., Björnson, E., Wilkins, J. T., Mortensen, M. B., Dufresne, L., Pencina, K. M., Pencina, M. J., Thanassoulis, G., & Sniderman, A. D. (2025) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 20

Icosapent Ethyl Supplementation and Cardiovascular Prevention—Implications of Evolving Data

Wilkins, J. T., & Lloyd-Jones, D. M. (2022) · JAMA Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 2